Home›Search›Cancer Biology and Therapy

Cancer Biology and Therapy

Taylor and Francis Ltd. · United States · Est. 1898

ISSN1538-4047eISSN1555-8576

SJR Q1✓ WOS SCIE✓ Scopus / SJR✓ DOAJ✓ Open Access

/ 100

High Trust

Score Breakdown

✓ WoS SCIE/SSCI+25

✓ Scopus Q1+25

✓ DOAJ Verified+15

Total75

Journal Impact Factor

This journal is indexed in Web of Science (JCR) and has an official Journal Impact Factor. View the current value on the journal’s page ↗

SJR Score

1.202

H-Index

152

CiteScore

View ↗

Scopus metric · on the journal’s page

SNIP

0.723

Total Works

5,210

Total Citations

167,022

2yr Mean Citedness

5.96

Free JIF alternative

Aims & Scope✦ Inferred from recent articles

This journal focuses on the biological mechanisms and therapeutic strategies for various cancers. Articles explore the roles of genetic alterations, cellular processes like metabolism and cell death (including cuproptosis and ferroptosis), and the tumor microenvironment in cancer progression. Research also covers the development of novel immunotherapies, targeted therapies, and the potential of natural products and synthetic biology in cancer treatment.

AI-summarised from recent articles · verify on publisher page →

⚡ Speed vs Prestige

How does this journal balance review speed with impact level?

weeks to review

Average · median is 15 wks

SJR Rank

Top 25% in field

General Information

Country / RegionUnited States

Primary LanguageEnglish

1st Year Published1898

FrequencySemimonthly, 2009-

StatusActive (last: 2026)

Total Publications5,210

Publisher OrgTaylor & Francis

OA Since2021

Visit Journal Website

Submission Info

Peer ReviewSingle-blind

Review Time~11 weeks

Acceptance Rate—

OA LicenseCC BY, CC BY-NC

OA Rate—

Ethics & Quality

COPE Member✗ No

OASPA Member✗ No

Not on Predatory Lists✓ Yes

Plagiarism Detection✓ Yes

📦 Long-term Preservation

Scholars PortalCLOCKSSNational Digital Preservation Program, China; Library of CongressLOCKSSPorticoPMC

Think.Check.Submit Compliance

thinkchecksubmit.org

10/12 · 83%

✅

Do you know the journal / publisher?

Taylor and Francis Ltd.

✅

Does the journal have a website?

✓ Linked

✅

Is the ISSN verified?

1538-4047 / 1555-8576

✅

Indexed in a trusted database?

WoS, Scopus, DOAJ

✅

Peer review process documented?

Single-blind

❌

Follows ethical publishing standards (COPE)?

N/A

❌

APC fees clearly disclosed?

N/A

✅

Not on predatory/blacklists?

✓ Clean

✅

Long-term digital preservation?

Scholars Portal, CLOCKSS, National Digital Preservation Program, China; Library of Congress, LOCKSS, Portico, PMC

✅

Plagiarism detection in place?

Yes

✅

Listed in DOAJ (verified OA)?

DOAJ verified

✅

Primary language documented?

English

Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.

Publication & Citation Trend

Articles published

Times cited

2019

2020

2021

2022

2023

2024

2025

2026

Source: OpenAlex · Note: citations accumulate over time so older years appear higher

SJR Quartile by Discipline

Scimago ranks this journal separately in each subject category — its quartile can differ by discipline.

PharmacologyQ1

Cancer ResearchQ2

Molecular MedicineQ2

OncologyQ2

Subject Classification

Web of Science Categories

Oncology

Scopus Categories

Molecular MedicinePharmacologyCancer ResearchOncology

Research Topics (OpenAlex)

Cancer-related Molecular PathwaysCancer, Hypoxia, and MetabolismRNA modifications and cancerCell death mechanisms and regulationCancer Cells and MetastasisEpigenetics and DNA MethylationCancer Research and TreatmentsMicroRNA in disease regulationCancer Genomics and DiagnosticsCancer-related molecular mechanisms research